Noel T. Brewer, PhD, former ACIP member, warns that the CDC's reduction from 17 to 11 recommended immunizations lacks transparency, which may lower uptake.

Patients taking ACE inhibitors and ARBs saw a 16% reduction in their risk of cancer progression (HR, 0.84; 95% CI, 0.71-0.99; ...

Affordability dominated GLP-1 decision-making, with many paying >$250 per fill, widespread use of coupons, and strong ...

Noel T. Brewer, PhD, former ACIP member, warns that the CDC's reduction from 17 to 11 recommended immunizations lacks ...

Noel T. Brewer, PhD, is a distinguished professor at the UNC Gillings School of Global Public Health and a former member of the Advisory Committee on Immunization Practices.

Rising housing costs may be more than a financial strain—they could be a health risk for low-income adults with heart failure. A new study found that a higher area-level housing cost burden was ...

Philip Mease, MD, shares how to individualize psoriatic disease treatment by weighing medication safety profiles, efficacy, and real-world lifestyle factors.

Rural cardiovascular disparities and limited specialist access are motivating AI decision-support adoption to help determine ...

As prescription drug pricing grows increasingly complex, Eric Levin, CEO and cofounder of Scripta, says Scripta aims to simplify the process for consumers trying to find the right medication at the ...

In this episode, Overcoming Access Barriers and Step-Edit Challenges in IgA Nephropathy Care, the panelists explore the ...

The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...

Measles outbreaks are emerging across the country, continuing the increasing trend in cases that began in 2025.